| 21.64 Delayed Data As of Sep 20 |  +0.50 / +2.37%Today’s Change | 9.04 Today|||52-Week Range 28.75 | +95.66% Year-to-Date |
| Invitae (NVTA) Dips More Than Broader Markets: What You Should Know Sep 13 / Zacks.com - Paid Partner Content |
| Previous close | 21.14 |
| Today’s open | 21.11 |
| Day’s range | 20.98 - 21.77 |
| Volume | 1,857,619 |
| Average volume (3 months) | 2,067,594 |
| Market cap | $2.1B |
| Earnings growth (last year) | +26.87% |
| Earnings growth (this year) | -9.65% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +116.50% |
| P/E ratio | NM |
| Price/Sales | 5.00 |
| Price/Book | 10.11 |
| Today’s change | Today’s % change | |
|---|---|---|
| NEONeogenomics Inc | +0.05 | +0.23% |
| NTRANatera Inc | +0.22 | +0.66% |
| GHDXGenomic Health Inc | +0.17 | +0.24% |
| --iKang Healthcare Gro... | 0.00 | 0.00% |
| Next reporting date | November 11, 2019 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $147.7M |
| Annual profit (last year) | -$129.4M |
| Net profit margin | -87.58% |
Sector Health Services |
Industry Medical/Nursing Services |
Chairman, President & Chief Executive Officer Sean Emerson George |
Chief Operating Officer & Secretary Elias Lee Bendekgey |
Corporate headquarters San Francisco, California |
